Shengzhe Zhang

State Key Laboratory Of Oncogenes And Related Genes
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Journal: Cell death and differentiation
Published: December 01, 2021

Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum.

Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum.

Journal: Theranostics
Published: March 05, 2021

Multiregion whole-genome sequencing depicts intratumour heterogeneity and punctuated evolution in ovarian clear cell carcinoma.

Multiregion whole-genome sequencing depicts intratumour heterogeneity and punctuated evolution in ovarian clear cell carcinoma.

Journal: Journal of medical genetics
Published: July 04, 2019

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.

Journal: eLife
Published: December 11, 2018

Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.

Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.

Journal: International journal of cancer
Published: July 30, 2018

Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.

Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 11, 2018

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.

Journal: Theranostics
Published: October 05, 2017

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.

Journal: Nature communications
Published: May 02, 2017

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.

Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.

Journal: Nature communications
Published: February 16, 2017

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer.

Journal: Molecular cancer therapeutics
Published: January 24, 2017

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.

Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.

Journal: Scientific reports
Published: July 17, 2015

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.

Journal: Theranostics
Published: July 07, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026